Emron Managed Care News 5-15-15

Emron Managed Care News

Blood Thinner Warfarin May Pose Greater Bleeding Risk for Obese: Study

Obese patients taking the blood thinner warfarin

appear to have almost twice the risk of severe stomach bleeding compared to their normal-weight counterparts, a new study suggests.

Medicaid Expansion Is Still A Tumultuous Fight In Several States

Five years after the Affordable Care Act passed, its Medicaid expansion provision is still causing huge fights in state legislatures.

Three Times More Americans Are Spending $100,000-Plus on Prescription Drugs

Pricey cancer drugs, expensive new cures for hepatitis and made-to-order drugs have driven U.S. prescription costs to new highs for some Americans, according to a report was issued Wednesday.

FDA Advisory Panel Voted 12 to 1 to Recommend Approval of Orkambi (lumacaftor/ivacaftor) for Cystic Fibrosis F508del Mutation

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration’s (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 12 to 1 to recommend that the FDA approve Orkambi (lumacaftor/ivacaftor) for use in people with cystic fibrosis (CF) ages 12 and older who have two copies of the F508del mutation in the CFTR gene.

How DNA sequencing is transforming the hunt for new drugs

Drug manufacturers have begun amassing enormous troves of human DNA in hopes of significantly shortening the time it takes to identify new drug candidates, a move some say is transforming the development of medicines. Baxter buys Sigma-Tau cancer drugs in $900m deal

Roche Lung-Cancer Drug Doubles Survival Rate in Trial

Roche Holding AG’s experimental immunotherapy for lung cancer doubled the likelihood of survival for some patients in a study, advancing development of a medicine that may help the Swiss drugmaker compete with Bristol-Myers Squibb Co. and Merck & Co.

Insulin Dosing Apps Unreliable, Error-Prone, Study Finds

A rrecent studyent study led by the Global eHealth Unit at the Imperial College London has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin.

FDA review questions Vertex’ CF combo

US regulators have questioned the clinical validity of Vertex’ cystic fibrosis combo Orkambi, which targets the most common form of the genetic condition, ahead of an advisory committee meeting this Tuesday (May 12). 

FDA approves Avelox for plague

The FDA today announced its approval of moxifloxacin for the prevention and treatment of pneumonic and septicemic plague in adult patients, according to a press release.

FDA approves Avelox for plague

The FDA today announced its approval of moxifloxacin for the prevention and treatment of pneumonic and septicemic plague in adult patients, according to a press release.